Back
Tango Therapeutics 10K Form
Sell
50
TNGX
Tango Therapeutics
Last Price:
8.42
Seasonality Move:
27.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TNGX News And Ratings
See the #1 stock for the next 7 days that we like better than TNGX
TNGX Financial Statistics
Sales & Book Value
Annual Sales: | $36.53M |
---|---|
Cash Flow: | $-23.93M |
Price / Cash Flow: | 0 |
Annual Sales: | $2.31 |
Price / Book: | 3.58 |
Profitability
EPS (TTM): | -1.12000 |
---|---|
Net Income (TTM): | $-116.49M |
Gross Margin: | -- |
Return on Equity: | -46.42% |
Return on Assets: | -29.16% |
Tango Therapeutics Earnings Forecast
Key Tango Therapeutics Financial Ratios
- The Research & Development expenses have been 315.38% of Revenue.
- The Net Earning history of TNGX is -278.54% of Total Revenues.
- Per Share Earnings over the last 4 years have been positive in 1 years.
Tango Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | TNGX |
Website: | tangotx.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 7.49 |
Quick Ratio: | 7.34 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
TNGX Technical Analysis vs Fundamental Analysis
Sell
50
Tango Therapeutics (TNGX)
is a Sell
Is Tango Therapeutics a Buy or a Sell?
-
Tango Therapeutics stock is rated a Sell
The current Tango Therapeutics [TNGX] share price is $8.28. The Score for TNGX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.